Roger Song
Stock Analyst at Jefferies
(4.39)
# 321
Out of 5,241 analysts
60
Total ratings
50.98%
Success rate
24.41%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Roger Song
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SABS SAB Biotherapeutics | Initiates: Buy | $11 | $3.55 | +209.86% | 1 | May 20, 2026 | |
| KLRA Kailera Therapeutics | Initiates: Buy | $48 | $19.62 | +144.65% | 1 | May 12, 2026 | |
| KNSA Kiniksa Pharmaceuticals International, | Maintains: Buy | $58 → $71 | $53.34 | +33.11% | 4 | Apr 28, 2026 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $6 → $10 | $1.89 | +429.10% | 1 | Apr 15, 2026 | |
| REPL Replimune Group | Downgrades: Hold | $13 → $2 | $4.70 | -57.45% | 3 | Apr 13, 2026 | |
| CTMX CytomX Therapeutics | Maintains: Buy | $8 → $16 | $3.64 | +339.56% | 4 | Mar 18, 2026 | |
| MANE Veradermics | Initiates: Buy | $75 | $100.07 | -25.05% | 1 | Mar 2, 2026 | |
| BIOA BioAge Labs | Upgrades: Buy | $9 → $62 | $16.37 | +278.74% | 3 | Feb 18, 2026 | |
| KRYS Krystal Biotech | Maintains: Buy | $310 → $371 | $293.30 | +26.49% | 2 | Feb 17, 2026 | |
| PTGX Protagonist Therapeutics | Maintains: Buy | $95 → $118 | $98.37 | +19.96% | 1 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $42 | $11.50 | +265.22% | 3 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $99 → $121 | $67.58 | +79.05% | 12 | Nov 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $57.50 | -21.74% | 1 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $6.26 | +155.59% | 1 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $432 → $564 | $566.80 | -0.49% | 1 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.22 | +309.84% | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $17 | $0.483 | +3,419.67% | 2 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $36 | $30.39 | +18.46% | 1 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $0.8951 | +570.32% | 1 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $3.06 | +128.76% | 1 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $26 | $6.14 | +323.45% | 1 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $28 | $8.96 | +212.50% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $2 → $7 | $4.45 | +57.30% | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $89 | $64.07 | +38.91% | 1 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $25 | $8.90 | +180.90% | 2 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $41 | $15.24 | +169.03% | 1 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $17.84 | +96.19% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $129 | $48.78 | +164.45% | 1 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $97 | $101.00 | -3.96% | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $110 | $28.40 | +287.32% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $35 | $2.74 | +1,177.37% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $4.27 | +110.77% | 1 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $210 | $31.67 | +563.09% | 1 | Sep 2, 2020 |
SAB Biotherapeutics
May 20, 2026
Initiates: Buy
Price Target: $11
Current: $3.55
Upside: +209.86%
Kailera Therapeutics
May 12, 2026
Initiates: Buy
Price Target: $48
Current: $19.62
Upside: +144.65%
Kiniksa Pharmaceuticals International,
Apr 28, 2026
Maintains: Buy
Price Target: $58 → $71
Current: $53.34
Upside: +33.11%
Allogene Therapeutics
Apr 15, 2026
Maintains: Buy
Price Target: $6 → $10
Current: $1.89
Upside: +429.10%
Replimune Group
Apr 13, 2026
Downgrades: Hold
Price Target: $13 → $2
Current: $4.70
Upside: -57.45%
CytomX Therapeutics
Mar 18, 2026
Maintains: Buy
Price Target: $8 → $16
Current: $3.64
Upside: +339.56%
Veradermics
Mar 2, 2026
Initiates: Buy
Price Target: $75
Current: $100.07
Upside: -25.05%
BioAge Labs
Feb 18, 2026
Upgrades: Buy
Price Target: $9 → $62
Current: $16.37
Upside: +278.74%
Krystal Biotech
Feb 17, 2026
Maintains: Buy
Price Target: $310 → $371
Current: $293.30
Upside: +26.49%
Protagonist Therapeutics
Feb 2, 2026
Maintains: Buy
Price Target: $95 → $118
Current: $98.37
Upside: +19.96%
Jan 22, 2026
Maintains: Buy
Price Target: $13 → $42
Current: $11.50
Upside: +265.22%
Nov 26, 2025
Maintains: Buy
Price Target: $99 → $121
Current: $67.58
Upside: +79.05%
Nov 13, 2025
Initiates: Buy
Price Target: $45
Current: $57.50
Upside: -21.74%
Oct 10, 2025
Initiates: Buy
Price Target: $16
Current: $6.26
Upside: +155.59%
Sep 2, 2025
Maintains: Buy
Price Target: $432 → $564
Current: $566.80
Upside: -0.49%
Aug 28, 2025
Initiates: Buy
Price Target: $5
Current: $1.22
Upside: +309.84%
Aug 22, 2025
Maintains: Buy
Price Target: $9 → $17
Current: $0.483
Upside: +3,419.67%
Aug 15, 2025
Assumes: Buy
Price Target: $36
Current: $30.39
Upside: +18.46%
Apr 1, 2025
Initiates: Buy
Price Target: $6
Current: $0.8951
Upside: +570.32%
Mar 14, 2025
Initiates: Buy
Price Target: $7
Current: $3.06
Upside: +128.76%
Feb 25, 2025
Initiates: Buy
Price Target: $26
Current: $6.14
Upside: +323.45%
Nov 21, 2024
Maintains: Buy
Price Target: $32 → $28
Current: $8.96
Upside: +212.50%
Nov 19, 2024
Upgrades: Buy
Price Target: $2 → $7
Current: $4.45
Upside: +57.30%
Oct 23, 2024
Initiates: Buy
Price Target: $89
Current: $64.07
Upside: +38.91%
Oct 16, 2024
Maintains: Buy
Price Target: $31 → $25
Current: $8.90
Upside: +180.90%
Oct 11, 2024
Initiates: Buy
Price Target: $41
Current: $15.24
Upside: +169.03%
Oct 8, 2024
Initiates: Buy
Price Target: $35
Current: $17.84
Upside: +96.19%
Sep 3, 2024
Maintains: Buy
Price Target: $108 → $129
Current: $48.78
Upside: +164.45%
Apr 17, 2024
Initiates: Buy
Price Target: $97
Current: $101.00
Upside: -3.96%
Mar 7, 2024
Initiates: Buy
Price Target: $110
Current: $28.40
Upside: +287.32%
Aug 31, 2022
Maintains: Buy
Price Target: $30 → $35
Current: $2.74
Upside: +1,177.37%
Jul 29, 2022
Initiates: Buy
Price Target: $9
Current: $4.27
Upside: +110.77%
Sep 2, 2020
Initiates: Buy
Price Target: $210
Current: $31.67
Upside: +563.09%